Frequency and prognostic value of SF3B1 mutations in myelodysplastic syndromes and mixed myelodysplastic/myeloproliferative syndromes

被引：0
|
作者：
Saada, Veronique
机构：
来源：
HEMATOLOGIE | 2012年 / 18卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：13 / 15
页数：3
相关论文
共 50 条
  • [1] Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
    Malcovati, Luca
    Papaemmanuil, Elli
    Bowen, David T.
    Boultwood, Jacqueline
    Della Porta, Matteo G.
    Pascutto, Cristiana
    Travaglino, Erica
    Groves, Michael J.
    Godfrey, Anna L.
    Ambaglio, Ilaria
    Galli, Anna
    Da Via, Matteo C.
    Conte, Simona
    Tauro, Sudhir
    Keenan, Norene
    Hyslop, Ann
    Hinton, Jonathan
    Mudie, Laura J.
    Wainscoat, James S.
    Futreal, P. Andrew
    Stratton, Michael R.
    Campbell, Peter J.
    Hellstrom-Lindberg, Eva
    Cazzola, Mario
    BLOOD, 2011, 118 (24) : 6239 - 6246
  • [2] SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications
    F Damm
    F Thol
    O Kosmider
    S Kade
    P Löffeld
    F Dreyfus
    A Stamatoullas-Bastard
    A Tanguy-Schmidt
    O Beyne-Rauzy
    S de Botton
    A Guerci-Bresler
    G Göhring
    B Schlegelberger
    A Ganser
    O A Bernard
    M Fontenay
    M Heuser
    Leukemia, 2012, 26 : 1137 - 1140
  • [3] SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications
    Damm, F.
    Thol, F.
    Kosmider, O.
    Kade, S.
    Loeffeld, P.
    Dreyfus, F.
    Stamatoullas-Bastard, A.
    Tanguy-Schmidt, A.
    Beyne-Rauzy, O.
    de Botton, S.
    Guerci-Bresler, A.
    Goehring, G.
    Schlegelberger, B.
    Ganser, A.
    Bernard, O. A.
    Fontenay, M.
    Heuser, M.
    LEUKEMIA, 2012, 26 (05) : 1137 - 1140
  • [4] Prognostic value and clinical feature of SF3B1 mutations in myelodysplastic syndromes: A meta-analysis
    Tang, Yaqiong
    Miao, Miao
    Han, Shiyu
    Qi, Jiaqian
    Wang, Hong
    Ruan, Changgeng
    Wu, Depei
    Han, Yue
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 133 : 74 - 83
  • [5] SF3B1 MUTATIONS AND THEIR IMPACT ON CELLULAR BIOENERGETICS IN MYELODYSPLASTIC SYNDROMES
    Hrustincova, A.
    Trsova, I.
    Krejcik, Z.
    Kundrat, D.
    Belickova, M.
    Kaisrlikova, M.
    Vesela, J.
    Klema, J.
    Rysavy, P.
    Suttnar, J.
    Hlavackova, A.
    Jonasova, A.
    Cermak, J.
    Merkerova, M. Dostalova
    LEUKEMIA RESEARCH, 2023, 128
  • [6] SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value
    Patnaik, Mrinal M.
    Lasho, Terra L.
    Hodnefield, Janice M.
    Knudson, Ryan A.
    Ketterling, Rhett P.
    Garcia-Manero, Guillermo
    Steensma, David P.
    Pardanani, Animesh
    Hanson, Curtis A.
    Tefferi, Ayalew
    BLOOD, 2012, 119 (02) : 569 - 572
  • [7] SF3B1 Mutations Are Prevalent in Myelodysplastic Syndromes with Ring Sideroblasts but Do Not Hold Independent Prognostic Value
    Patnaik, Mrinal M.
    Lasho, Terra L.
    Hodnefield, Janice M.
    Knudson, Ryan A.
    Ketterling, Rhett P.
    Al-Kali, Aref
    Garcia-Manero, Guillermo
    Steensma, David P.
    Pardanani, Animesh
    Hanson, Curtis A.
    Tefferi, Ayalew
    BLOOD, 2011, 118 (21) : 213 - 213
  • [8] Prognostic significance of SF3B1 mutations in patients with myelodysplastic syndromes: A meta-analysis
    Jafari, Pourya Arbab
    Sadeghian, Mohammad Hadi
    Miri, Hamid Heidarian
    Sadeghi, Ramin
    Bagheri, Ramin
    Lavasani, Sroush
    Souri, Saeid
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 145
  • [9] Circular RNAs in Myelodysplastic Syndromes and Impact of SF3B1 Mutations on Their Expression
    Merkerova, Michaela Dostalova
    Kundrat, David
    Krejcik, Zdenek
    Hrustincova, Andrea
    Trsova, Iva
    Szikszai, Katarina
    Kaisrlikova, Monika
    Vesela, Jitka
    Klema, Jiri
    Cermak, Jaroslav
    Belickova, Monika
    BLOOD, 2021, 138
  • [10] SF3B1 Mutations Negatively Predict for Response to Immunosuppressive Therapy in Myelodysplastic Syndromes
    Zhang, Qing
    Haider, Mintallah
    Al Ali, Najla H.
    Lancet, Jeffrey E.
    Epling-Burnette, Pearlie K.
    List, Alan F.
    Padron, Eric
    Komrokji, Rami S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (06): : 400 - +
12345